Advertisement
Advertisement

PHGE

PHGE logo

BiomX Inc.

4.89
USD
Sponsored
+0.01
+0.31%
Mar 25, 16:00 UTC -4
Closed
exchange

Pre-Market

4.90

+0.01
+0.22%

PHGE Earnings Reports

Positive Surprise Ratio

PHGE beat 12 of 23 last estimates.

52%

Next Report

Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q4 25 (Revenue/ EPS)
--
/
--
Implied change from Q1 25 (Revenue/ EPS)
--
/
--

BiomX Inc. earnings per share and revenue

On Feb 19, 2026, PHGE reported earnings of -8.17 USD per share (EPS) for Q4 25, missing the estimate of -4.70 USD, resulting in a -73.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.38% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
logo
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
logo
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
logo
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
logo
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
logo
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
logo
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
FAQ
For Q4 2025, BiomX Inc. reported EPS of -$8.17, missing estimates by -73.75%, and revenue of $0.00, 0% as expectations.
The stock price moved down -0.38%, changed from $5.25 before the earnings release to $5.23 the day after.
The next earning report is scheduled for May 13, 2026.
Based on -- analysts, BiomX Inc. is expected to report EPS of -- and revenue of -- for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement